AnteoTech Ltd (AU:ADO) has released an update.
AnteoTech Ltd has announced a significant five-year purchase agreement with the Serum Institute of India, the world’s largest vaccine manufacturer, ensuring a minimum of US$370,000 in annual orders for AnteoTech’s AnteoBind product. The deal underscores AnteoTech’s expansion into the life sciences market and is expected to exceed the minimum order value as the partnership strengthens and demand grows. The agreement, which includes a framework for increased future orders, solidifies AnteoTech’s role in supporting the Serum Institute’s vaccine development and production.
For further insights into AU:ADO stock, check out TipRanks’ Stock Analysis page.
